Zheng Quan Zhi Xing·2025-08-12 16:13Core Viewpoint - The document outlines the fundraising management system of Liaoning Chengda Biological Co., Ltd., emphasizing the proper use and management of raised funds to enhance efficiency and protect investors' rights [1]. Group 1: Fundraising Purpose and Management - The funds raised must be used specifically for designated purposes, primarily in line with national industrial policies and sustainable development principles, focusing on enhancing the company's competitiveness and innovation capabilities [2]. - The board of directors and senior management are responsible for ensuring the proper use of raised funds and must not engage in any unauthorized changes to their intended use [2][3]. - The company must disclose the usage of raised funds in accordance with relevant laws and regulations [3]. Group 2: Fund Storage and Supervision - Upon receipt of the raised funds, the company must establish a special account for centralized management and usage, ensuring that no non-fund-related transactions occur in this account [4][5]. - A tripartite supervision agreement must be signed with the sponsoring institution or independent financial advisor and the commercial bank holding the funds, detailing the management and oversight of the funds [5][6]. Group 3: Fund Usage Approval Process - The approval process for using raised funds involves multiple levels of management, requiring detailed records of fund inflows and outflows [6][7]. - The company must adhere to the usage plan outlined in the issuance application documents and disclose any significant deviations from this plan [7][8]. Group 4: Management of Idle Funds - Idle funds may be temporarily used for cash management, provided that such management does not affect the normal progress of investment plans [9][10]. - The company can use idle funds to supplement working capital, but this must be approved by the board and disclosed accordingly [10][11]. Group 5: Changes in Fund Usage - Any changes in the intended use of raised funds must be approved by the board and disclosed, ensuring that new projects align with the company's main business [12][13]. - The company must conduct feasibility analyses for new projects and ensure that they enhance competitiveness and innovation [13][14]. Group 6: Accountability and Reporting - The company is required to maintain accurate records of fund usage and report on the actual use of raised funds, including any discrepancies from planned usage [15][16]. - The board must regularly review the management and usage of raised funds and disclose findings in a special report [15].